Litigation Details for BIOGEN INTERNATIONAL GMBH v. ZYDUS PHARMACEUTICALS (USA) INC. (D.N.J. 2019)
✉ Email this page to a colleague
BIOGEN INTERNATIONAL GMBH v. ZYDUS PHARMACEUTICALS (USA) INC. (D.N.J. 2019)
Docket | ⤷ Try a Trial | Date Filed | 2019-02-14 |
Court | District Court, D. New Jersey | Date Terminated | 2019-04-17 |
Cause | 35:271 Patent Infringement | Assigned To | Brian R. Martinotti |
Jury Demand | None | Referred To | Lois H. Goodman |
Patents | 6,509,376; 7,320,999; 7,619,001; 8,399,514 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in BIOGEN INTERNATIONAL GMBH v. ZYDUS PHARMACEUTICALS (USA) INC.
Details for BIOGEN INTERNATIONAL GMBH v. ZYDUS PHARMACEUTICALS (USA) INC. (D.N.J. 2019)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2019-02-14 | 1 | against Zydus for patent infringement of U.S. Patent No. 6,509,376 (“the ’376 patent”), in Biogen International…for patent infringement of U.S. Patent No. 7,619,001 (“the ’001 patent”) arising under the patent laws…against Zydus for patent infringement of U.S. Patent Nos. 8,399,514 (“the ’514 patent”) and 7,320,999 …Delaware against Zydus for patent infringement of the ’514 patent and the ’999 patent in a case captioned …21 C.F.R. § 314.95(c) as to the ’514 patent and the ’999 patent. The First New Jersey Suit and the First | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |